REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.73
-0.52 (-5.07%)
Jul 24, 2026, 4:00 PM EDT - Market closed
REGENXBIO Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, REGENXBIO stock has a consensus rating of "Buy" and an average price target of $24.27. The average 1-year stock price forecast is 149.43% higher than the current stock price, while the lowest is $10 (+2.77%) and the highest is $50 (+413.87%).
Price Target: $24.27 (+149.43%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for REGENXBIO stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $26 | Buy | Reiterates | $26 | +167.21% | Jun 30, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $16 | Buy | Maintains | $16 | +64.44% | Jun 25, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $42 | Buy | Reiterates | $42 | +331.65% | Jun 25, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $27 → $32 | Buy | Maintains | $27 → $32 | +228.88% | Jun 23, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +74.72% | May 15, 2026 |
Financial Forecast
Revenue This Year
237.89M
from 170.44M
Increased by 39.57%
Revenue Next Year
247.51M
from 237.89M
Increased by 4.05%
EPS This Year
-2.79
from -3.76
EPS Next Year
-2.54
from -2.79
EPS and Forward PE are based on non-GAAP adjusted numbers.